title: Synthesis of novel trans-4-(substituted-benzamido)-3,4-dihydro-2H-benzo[b]-pyran-3-ol derivatives as potential anticonvulsant agents with a distinctive binding profile.
authors.affiliation: SmithKline Beecham Pharmaceuticals, Harlow, Essex, UK.
authors.forename: W N
authors.initials: WN
authors.lastname: Chan
authors.forename: J M
authors.initials: JM
authors.lastname: Evans
authors.forename: M S
authors.initials: MS
authors.lastname: Hadley
authors.forename: H J
authors.initials: HJ
authors.lastname: Herdon
authors.forename: J C
authors.initials: JC
authors.lastname: Jerman
authors.forename: H K
authors.initials: HK
authors.lastname: Morgan
authors.forename: T O
authors.initials: TO
authors.lastname: Stean
authors.forename: M
authors.initials: M
authors.lastname: Thompson
authors.forename: N
authors.initials: N
authors.lastname: Upton
authors.forename: A K
authors.initials: AK
authors.lastname: Vong
mesh_terms: D000818:Animals; D000927:Anticonvulsants / Q000138:chemical synthesis* / Q000378:metabolism; D001549:Benzamides / Q000138:chemical synthesis* / Q000378:metabolism; D001578:Benzopyrans / Q000138:chemical synthesis* / Q000378:metabolism; D001665:Binding Sites; D051379:Mice; D011869:Radioligand Assay; D051381:Rats; D013237:Stereoisomerism; D014316:Tritium
chemical_list: D000927:Anticonvulsants; D001549:Benzamides; D001578:Benzopyrans; C102319:SB 204269; D014316:Tritium